Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults
Clinical trial NCT02431364 · TERMINATED
Trial details
- NCT number
- NCT02431364
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-26
- Primary completion
- 2015-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.